ADAP
Adaptimmune Therapeutics
ADAP
ADAP
47 hedge funds and large institutions have $255M invested in Adaptimmune Therapeutics in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 9 closing their positions.
Holders
47
Holders Change
+4
Holders Change %
+9.3%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
14
Reduced
10
Closed
9
Calls
$168K
Puts
$95K
Net Calls
+$73K
Net Calls Change
+$73K